Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:05am, Tuesday, 14'th May 2024
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
My Dividend Stock Portfolio: New April Dividend Record - 101 Holdings With 22 Buys
08:10am, Tuesday, 14'th May 2024
Portfolio changes in April focus on BDCs, aiming to increase dividend income by at least $100 each month. Dividend income hit a new all-time record for April of $736, basically flat Y/Y and up 12% seq
Alzamend Neuro Announces Initial Closing of Private Placement
08:00am, Tuesday, 14'th May 2024
ATLANTA--(BUSINESS WIRE)---- $ABBV #15_Percent_Interest_Bearing_Preferred_Stock--Alzamend Neuro Announces Initial Closing of Private Placement; Investor Purchase Up to $25 Million of Preferred Shares;
3 Magnificent Stocks That Are Passive Income Machines
06:30am, Tuesday, 14'th May 2024
Eli Lilly is an ideal stock for growth and dividends. AbbVie is a Dividend King with a bright future.
What Is the Dividend Payout for AbbVie Stock?
11:09am, Monday, 13'th May 2024
AbbVie's best-selling product recently lost its patent protection, threatening the company's future results. The drugmaker's R&D pipeline, however, is more promising than it's getting credit for.
- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders NORTH C
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Landos Bioph
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
03:50am, Saturday, 11'th May 2024
Novo Nordisk's Ozempic has changed the business entirely. Eli Lilly is a diversified giant with GLP-1 tailwinds.
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
09:30am, Friday, 10'th May 2024
AbbVie is a diversified healthcare company that has been able to strengthen its portfolio via acquisitions. AT&T has faced a lot of negative press in recent years but its fundamentals remain sound.
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
02:04pm, Tuesday, 07'th May 2024
Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because much hinges on underlying breakthroughs.
AbbVie Tracking for New Highs in 2024
11:46am, Tuesday, 07'th May 2024
Shares of AbbVie NYSE: ABBV fell hard in the wake of its Q1 earnings report, but the dip is over. The market response to slowing Humira sales is overshadowed by strength in the non-Humira portfolio, r
AbbVie to Present at the Bank of America Securities Healthcare Conference
08:00am, Monday, 06'th May 2024
NORTH CHICAGO, Ill. , May 6, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024.
3 Reasons to Buy AbbVie Stock on the Dip
01:44pm, Sunday, 05'th May 2024
AbbVie's revenue grew slightly in the first quarter despite Humira losing steam. The company's successors to Humira are proving worthy.
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:06am, Wednesday, 01'st May 2024
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
5 Dividend King Blue-Chips That Lagged the Market Are Incredible May Buys
08:43am, Wednesday, 01'st May 2024
∴ Sponsored: Want to Retire Early?
